Description: 2021 ImpACT Conference -Session 8E: Flow Reinsurance on Trial: You Decide 10.27.21 Recording

Description: Almost half of recent FDA approvals have been for orphan drugs. This trend is expected to continue in 2023. Orphan drugs are priced more than 30 times higher than non-orphan drugs, therefore their cost burden in aggregate has the potential to overwhelm the budgets of payers, especially that of smaller health plans. Hear how the cost impact analysis for smaller health plans require different considerations than for a larger health plan when modeling the impact of rare diseases.

Description: Explore various aspects of the Asian reinsurance market in this webcast. Learn about the landscape within the market as speakers cover key topics like product perspectives, structured solutions and emerging trends and issues. Take an in-depth look at the post COVID-19 impact, as well as regulatory considerations that could affect the Asian reinsurance industry. Secure your spot in this opportunity and dive into the direction of this marketspace.

Description: Come experience an informative and invigorating webcast focused on an overview of the reinsurance market. Discover the opportunities and challenges that this market can create and how to best understand them. You can also expect investment within the reinsurance market to be a particular highlighted topic. Explore an overview of key components of asset strategies and develop a knowledge base on how to fully comprehend and shape the reinsurance business. If you're ready to elevate your understanding of reinsurance, then tune in to this webcast.

Description: At the conclusion of the first part, attendees will be able to describe sources of reserve redundancy for products under Principle Based Reserve (PBR) and products under Commissioners' Annuity Reserve Valuation Method (CARVM). Such products include Term Life, Whole Life, Universal Life, and Fixed Annuity with and without rider. We will also review sources of capital redundancy from the C-1 factor under Risk-Based Capital (RBC) and assets such as Unrated Asset Credit Fund can have high C-1 factor even if its risks are limited. At the conclusion of the second part, the attendees will learn about potential Reserve Relief reinsurance solutions. Such solutions can provide Reserve Relief for annuity and term life businesses, as well as potential innovative asset-side solutions. Asset managers can structure assets that the C-1 factor aligned with the corresponding risk.

Description: The surge in interest rates over the past few years presents opportunities for life insurers to enhance their Asset and Liability Management (ALM) positions through asset rebalancing to narrow the duration gap and secure higher risk-adjusted yields. This webcast introduces a robust, efficient and readily-executable, liability-driven strategic asset allocation (SAA) framework and implementation considerations. At the conclusion of the webcast, attendees will learn about the key objectives and practical considerations for a successful SAA.

Description: Come experience an informative and invigorating webcast focused on an overview of the reinsurance market. Discover the opportunities and challenges that this market can create and how to best understand them. You can also expect investment within the reinsurance market to be a particular highlighted topic. Explore an overview of key components of asset strategies and develop a knowledge base on how to fully comprehend and shape the reinsurance business. If you're ready to elevate your understanding of reinsurance, then tune in to this webcast.

Description: Join us for the It Takes a Village: Insurance Product Development in the Digital webcast. Focuses will be directed toward a variety of disciplines within the actuarial science industry. We will also take a deep dive into UW, Technology Product and Marketing and Distribution. Don't miss the opportunity to bring digital insurance products to life and discover what the process of product evolution.

Description: Come discuss how reinsurers can work side by side with insurer to better develop products, and lift in the areas that reinsurers have more experience, help matching products with distributions (or vice versa) and provide advanced technologies associated with tools and software. The speakers will also present Direct to Consumer plan from various points of view, i.e., distributors, carriers, and reinsurers. Some case studies will also be presented where traditional reinsurers and asset-intensive reinsurers helped insurers bring products to life.